Sickle Cell Disease Stem Cell Treatments
A Regenerative Approach to Blood Disorders
Sickle Cell Disease (SCD) is a genetic blood disorder that causes red blood cells to assume a rigid, sickle-like shape. These cells break down prematurely and block blood flow, leading to pain, anemia, infections, and organ damage.
At 1 STEM CELL, we focus on advanced stem cell therapies that target the root cause of this condition — the production of abnormal hemoglobin. By using umbilical cord–derived mesenchymal stem cells (MSCs), our goal is to restore normal blood cell production, reduce inflammation, and improve oxygen delivery throughout the body.
Unlike traditional transfusions or medications that only manage symptoms, regenerative therapy works to repair and regenerate bone marrow tissue, encouraging the development of healthy red blood cells and reducing the frequency of painful crises.
Our personalized protocols combine scientific innovation and safety, offering hope for patients seeking alternatives to bone marrow transplants or lifelong drug therapy.
Questions and Answers About Sickle Cell Stem Cell Treatments
Q: How does stem cell therapy help treat Sickle Cell Disease?
Stem cells help repair and regenerate bone marrow, improving the body’s ability to produce healthy red blood cells and reducing sickling and inflammation.
Q: What type of stem cells are used?
1 STEM CELL uses umbilical cord–derived mesenchymal stem cells, known for their regenerative properties and ability to reduce immune system overactivity.
Q: Is stem cell therapy a cure for Sickle Cell Disease?
While it’s not yet considered a complete cure, stem cell therapy can significantly reduce symptoms, pain crises, and transfusion dependence, improving quality of life.
Q: How is the procedure performed?
The therapy is administered through a minimally invasive intravenous infusion, typically completed in one outpatient session under medical supervision.
Q: Who can benefit from this treatment?
Patients with mild to moderate forms of Sickle Cell Disease, or those who are not candidates for bone marrow transplant, may benefit from stem cell therapy.